Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study Investigating the Route of Administration of Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

NCT00082459 is registered in ClinicalTrials.gov with Agenus Inc. as lead sponsor.

NCT NCT00082459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00082459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study Investigating the Route of Administration of Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma
Lead sponsor
Agenus Inc.
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2002
Completion date
December 31, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma